Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1989
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1991 1
1992 4
1993 1
1996 2
1997 1
1998 2
1999 1
2003 1
2005 2
2006 2
2007 1
2008 1
2009 4
2010 1
2011 3
2012 7
2013 5
2015 3
2016 3
2017 2
2018 5
2019 3
2020 5
2021 2
2022 3
2023 4
2024 6
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Clinical review: intensive care unit acquired weakness.
Hermans G, Van den Berghe G. Hermans G, et al. Crit Care. 2015 Aug 5;19(1):274. doi: 10.1186/s13054-015-0993-7. Crit Care. 2015. PMID: 26242743 Free PMC article. Review.
A substantial number of patients admitted to the ICU because of an acute illness, complicated surgery, severe trauma, or burn injury will develop a de novo form of muscle weakness during the ICU stay that is referred to as "intensive care unit acquired weakness" (ICUAW). . …
A substantial number of patients admitted to the ICU because of an acute illness, complicated surgery, severe trauma, or burn injury will de …
Spinal muscular atrophy.
D'Amico A, Mercuri E, Tiziano FD, Bertini E. D'Amico A, et al. Orphanet J Rare Dis. 2011 Nov 2;6:71. doi: 10.1186/1750-1172-6-71. Orphanet J Rare Dis. 2011. PMID: 22047105 Free PMC article. Review.
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. Estimated incidence is 1 in 6,000 to 1 in 1 …
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neu …
Early onset hereditary neuronopathies: an update on non-5q motor neuron diseases.
Zambon AA, Pini V, Bosco L, Falzone YM, Munot P, Muntoni F, Previtali SC. Zambon AA, et al. Brain. 2023 Mar 1;146(3):806-822. doi: 10.1093/brain/awac452. Brain. 2023. PMID: 36445400 Free PMC article. Review.
Despite the advances of next generation sequencing, more than 60% of patients with HMN remain genetically uncharacterized. Of note, we are increasingly aware of the broad range of phenotypes caused by pathogenic variants in the same gene and of the considerable clinical an …
Despite the advances of next generation sequencing, more than 60% of patients with HMN remain genetically uncharacterized. Of note, w …
Sepsis-induced myopathy.
Callahan LA, Supinski GS. Callahan LA, et al. Crit Care Med. 2009 Oct;37(10 Suppl):S354-67. doi: 10.1097/CCM.0b013e3181b6e439. Crit Care Med. 2009. PMID: 20046121 Free PMC article. Review.
Abundant evidence indicates that sepsis induces a myopathy characterized by reductions in muscle force-generating capacity, atrophy (loss of muscle mass), and altered bioenergetics. ...The mechanisms leading to sepsis-induced changes in skeletal mus
Abundant evidence indicates that sepsis induces a myopathy characterized by reductions in muscle force-generating capacity, …
The time course of disuse muscle atrophy of the lower limb in health and disease.
Hardy EJO, Inns TB, Hatt J, Doleman B, Bass JJ, Atherton PJ, Lund JN, Phillips BE. Hardy EJO, et al. J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2616-2629. doi: 10.1002/jcsm.13067. Epub 2022 Sep 14. J Cachexia Sarcopenia Muscle. 2022. PMID: 36104842 Free PMC article. Review.
Short, intermittent episodes of disuse muscle atrophy (DMA) may have negative impact on age related muscle loss. There is evidence of variability in rate of DMA between muscles and over the duration of immobilization. ...This review aims to establish and comp …
Short, intermittent episodes of disuse muscle atrophy (DMA) may have negative impact on age related muscle loss. There …
Non-Pharmacological Strategies for Managing Sarcopenia in Chronic Diseases.
Hu J, Wang Y, Ji X, Zhang Y, Li K, Huang F. Hu J, et al. Clin Interv Aging. 2024 May 15;19:827-841. doi: 10.2147/CIA.S455736. eCollection 2024. Clin Interv Aging. 2024. PMID: 38765795 Free PMC article. Review.
Maintaining the appropriate frequency and intensity of resistance training can help prevent muscle atrophy and effectively reduce inflammation. Although aerobic exercise has limited ability to improve skeletal muscle mass, it does have some positive effects o …
Maintaining the appropriate frequency and intensity of resistance training can help prevent muscle atrophy and effectively red …
Limb muscle size and contractile function in adults with cystic fibrosis: A systematic review and meta-analysis.
Wu K, Mendes PL, Sykes J, Stephenson AL, Mathur S. Wu K, et al. J Cyst Fibros. 2021 Sep;20(5):e53-e62. doi: 10.1016/j.jcf.2021.02.010. Epub 2021 Feb 27. J Cyst Fibros. 2021. PMID: 33648899 Free article.
BACKGROUND: There is conflicting evidence regarding the presence of limb muscle impairments in adults with cystic fibrosis (CF), and the factors associated with these muscle impairments. ...There is no significant difference between adults with CF and control …
BACKGROUND: There is conflicting evidence regarding the presence of limb muscle impairments in adults with cystic fibrosis (CF …
Avoiding Respiratory and Peripheral Muscle Injury During Mechanical Ventilation: Diaphragm-Protective Ventilation and Early Mobilization.
Schreiber A, Bertoni M, Goligher EC. Schreiber A, et al. Crit Care Clin. 2018 Jul;34(3):357-381. doi: 10.1016/j.ccc.2018.03.005. Crit Care Clin. 2018. PMID: 29907270 Review.
Both limb muscle weakness and respiratory muscle weakness are exceedingly common in critically ill patients. ...Limb muscle weakness persists for months after discharge from intensive care and results in poor long-term functional status and qual …
Both limb muscle weakness and respiratory muscle weakness are exceedingly common in critically ill patients. ...Limb
Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.
LoRusso S, Weiner B, Arnold WD. LoRusso S, et al. Neurotherapeutics. 2018 Oct;15(4):872-884. doi: 10.1007/s13311-018-00679-z. Neurotherapeutics. 2018. PMID: 30341596 Free PMC article. Review.
Myotonic dystrophy is an autosomal dominant muscular dystrophy not only associated with muscle weakness, atrophy, and myotonia but also prominent multisystem involvement. ...In contrast, myotonic dystrophy type 2 is adult-onset or late-onset, has proximal pre …
Myotonic dystrophy is an autosomal dominant muscular dystrophy not only associated with muscle weakness, atrophy, and m …
An update on diagnostic options and considerations in limb-girdle dystrophies.
Angelini C, Giaretta L, Marozzo R. Angelini C, et al. Expert Rev Neurother. 2018 Sep;18(9):693-703. doi: 10.1080/14737175.2018.1508997. Epub 2018 Aug 21. Expert Rev Neurother. 2018. PMID: 30084281 Review.
Limb-girdle muscular dystrophies (LGMDs) encompass a clinically heterogeneous group of rare, genetic progressive muscle disorders presenting with weakness and atrophy of predominant pelvic and shoulder muscles. ...The management of the main clinical re
Limb-girdle muscular dystrophies (LGMDs) encompass a clinically heterogeneous group of rare, genetic progressive muscle
71 results